Citation Impact
Citing Papers
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells
2012
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
2008 Standout
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
2011
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study
2016
Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
2010
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
2013
Borderline HER‐2 breast cancer cases: Histochemical versus real‐time PCR analysis and impact of different cut‐off values
2007
NMR-based metabolic profiling of human hepatoma cells in relation to cell growth by culture media analysis
2006
HER-2/neu Assessment in Breast Cancer Using the Original FDA and New ASCO/CAP Guideline Recommendations
2008
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer
2010
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
Intraneural perineurioma
2009
Nodal and splenic marginal zone B cell lymphomas
2005
PGDS, A Novel Technique Combining Chromogenic In Situ Hybridization and Immunohistochemistry for the Assessment of ErbB2 (HER2/neu) Status in Breast Cancer
2007
The WHO Classification of Tumors of the Nervous System
2002 Standout
Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations
2008
Cancer genetics of epigenetic genes
2007
Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies
2013
Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics
2010 StandoutNobel
High Clinical Response Rate of S ézary Syndrome to Immunomodulatory Therapies
2011
Role of AID in Tumorigenesis
2007 StandoutNobel
Macrophages in immunoregulation and therapeutics
2023 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Myelodysplasia with fibrosis: a distinct entity?
2001
Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?
2003
The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy
2005
Antibody therapy of cancer
2012 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
C-MET as a new therapeutic target for the development of novel anticancer drugs
2010
Hair follicle–derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma
2015
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Unique features of long non-coding RNA biogenesis and function
2015 Standout
Configuration of the TP53 Gene as an Independent Prognostic Parameter of Myelodysplastic Syndrome
2003
Immunological memory cells
2018 Standout
Epigenetic modifications and human disease
2010 Standout
The AID Dilemma
2012 StandoutNobel
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
2014 Standout
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
2009
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Comparative genomic hybridization analysis of primary cutaneous B‐cell lymphomas: Identification of common genomic alterations in disease pathogenesis
2002
Molecular pathogenesis of mantle cell lymphoma
2012
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
2008
Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon‐inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation
2012
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
A novel human B cell subpopulation representing the initial germinal center population to express AID
2006
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
2002
Monoclonal Antibodies for Cancer Therapy
2012 StandoutNobel
2016 US lymphoid malignancy statistics by World Health Organization subtypes
2016 Standout
Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcripts
2012
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
2005
High-resolution whole genome tiling path array CGH analysis of CD34+ cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
2008
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues
2006
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies
2021
Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes
2007
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Evaluation of Her-2/neu Status in Carcinomas With Amplified Chromosome 17 Centromere Locus
2006
Performance of Chromogenic In Situ Hybridization on Testing HER2 Status in Breast Carcinomas With Chromosome 17 Polysomy and Equivocal (2+) HercepTest Results
2009
World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes
2007
Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution
2001
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
2007
Works of Blanca Espinet being referenced
Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours
2010
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistry
2005
Absence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas
2011
Mycosis Fungoides and Sézary Syndrome
2013
Gastrointestinal Involvement in Mantle Cell Lymphoma: A Prospective Clinic, Endoscopic, and Pathologic Study
2006
Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes
2004
Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment
2006
Translocation (11;14)(q13;q32) and Preferential Involvement of Chromosomes 1, 2, 9, 13, and 17 in Mantle Cell Lymphoma
1999
Clonal proliferation of cyclin D1–positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?
2005
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
2009
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
2011
Intraosseous intraneural perineurioma: report of a case with morphological, immunohistochemical and FISH study.
2004
Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization.
2004
Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
2005
MLL intrachromosomal amplification in a pre-B acute lymphoblastic leukemia.
2003
Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.
2001
Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes
2000